Baird Medical Investment Stock Today
| BDMDW Stock | 0.10 0.03 23.08% |
Performance12 of 100
| Odds Of DistressLess than 10
|
Baird Medical is selling for under 0.1 as of the 22nd of January 2025; that is 23.08 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.1. Baird Medical has less than a 10 % chance of experiencing some financial distress in the next two years of operation and had a good performance during the last 90 days. The performance scores are derived for the period starting the 23rd of December 2024 and ending today, the 22nd of January 2025. Click here to learn more.
IPO Date 2nd of October 2024 | Category Healthcare |
Baird Medical is entity of United States. It is traded as Stock on NASDAQ exchange. More on Baird Medical Investment
Moving against Baird Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Baird Stock Highlights
| Chairwoman CEO | Haimei Wu | ||||
| Thematic Idea | Drugs (View all Themes) | ||||
| Business Concentration | Medical Equipment, Medical Devices, Healthcare, Drugs, Medical Devices, Healthcare (View all Sectors) | ||||
Baird Medical can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Baird Medical's financial leverage. It provides some insight into what part of Baird Medical's total assets is financed by creditors.
| |||||
Baird Medical Investment (BDMDW) is traded on NASDAQ Exchange in USA. It is located in Room 202, Guangzhou, China, 510000 and employs 148 people. Baird Medical is listed under Medical Equipment category by Fama And French industry classification. The company classifies itself under Healthcare sector and is part of Medical Devices industry.
Check Baird Medical Probability Of Bankruptcy
Baird Medical Historical Income Statement
Baird Stock Against Markets
Baird Medical Corporate Executives
Elected by the shareholders, the Baird Medical's board of directors comprises two types of representatives: Baird Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Baird. The board's role is to monitor Baird Medical's management team and ensure that shareholders' interests are well served. Baird Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Baird Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Rongjian Lu | CTO GM | Profile |
Additional Tools for Baird Stock Analysis
When running Baird Medical's price analysis, check to measure Baird Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Baird Medical is operating at the current time. Most of Baird Medical's value examination focuses on studying past and present price action to predict the probability of Baird Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Baird Medical's price. Additionally, you may evaluate how the addition of Baird Medical to your portfolios can decrease your overall portfolio volatility.